10
000J.200B
Diaguostc Pofnt PailgyLabs
CUZD EIZCZJDOCTEE140LOODCOOTTETDZETTTUZZ3
4ot
n0nLCAOncfidEC 4C
Rlo
Sloion J n oclki 95fn
SARVODAYA HOSPITAL
Dr: Capt Atul Kapila Retd MD Path
KJ-7. Kavi
Ghaziabad U.P
Ragn o MCI 3458
Patient
Referred
VERMA
Lab Serial No: 07
Receiving
6.00.3OAM
Ward No
Reporting Date
8.29.O7AM
UHD No
0223
391503
Date TAT
2 Hours 29 Mlnute
Investiqation
Observed Value
Unit
Biological Ref Interval
HEMATOLOGY
PROTHROMBIN TIME
NORMAL CONTROL VALUE
13.0
second s
PATIENT VALUE
7.5
second s
International Nolmalized Ratio
1.37
Specimen
PT PLASMA
Comment
INR is the parameter of choice in monitoring adequacy of oral antcoagulant therapy: Appropriate therapeutic range
varies with the disease and treatment intensity
Prolonged INR suggests potential bleeding disorder
bleeding complications
Results should be clinically correlaled
Test conducted on Citrated plasma
RecommendedTherapeutic range fcr Oral Anticoagulant therapy
INR 2.0-3.0
Treatmient of Venous thrombosis Pulmonary embolism
Prophylaxis of Venous thrombosis High risk surgery :
Prevention of systemic embolism In tissue heart valves.
AMI Valvular heart disease Atrial fibrillatior.
Bileaflet mechanical valve in aortic position
INR 2 5-3 5:
Mechanical prosthetic valves
Systemic recurrent emboli
Comments Prothrombin time measures the extrinsic coagulation pathway which consists of activated Factor VII VIla .
Tissue factor and Proteins of the common patnway Factors X. V. II Fibrinogen : This assay IS used to control long
term oral anticoagulant therapy. evaluation of liver function to evaluate coagulation disorders specially factors
involved 1n the extrinsic pathway like Factors V. VII. X. Protlirombin Fibrinogen.
END OF REPORT
Page 1 of
04 4
FACILITIES
FOR HORMONES ASSAYS FNAC. HISTOPATHOI OGY. BONE MAKROW ASPIRATION BIOPSY WITH MICRO PHOTOGRAPHS
NOTE
ABOVE MENTIONED FINDINGS ARF A PROFFSSIONAL OPINION AND NOT
A FINAI DIAGNOSIS. ALL LABORATORY TESTS OTHER
INVESTIGATION RESULTS ARE TO BE CORELA ED CLinic PATHOLOGICALLV. DISLREPANCIES. F ANY. NECESSITATE REVIEWIREPEAT OF THE TESTS
NOTVVETILD FoR MEDICOLECAALBUREOSE
MMr
Nagar.